According to these data, we think that thrombin imbalance could contribute to progression of CCM lesions, by enhancing disruption of the BBB tight junction, mediated by MMP9 [51], and we suggest that this may be a valid field for further investigations. The gene discussed is MMP9; the disease is cerebral cavernous malformation.